News & Analysis on Clinical Trial Services & Contract Research And Development
People on the move
By Melissa Fassbender
- Last updated on
The executive leadership team has been “revamped,” according to the CDMO.
The company has named Dr. Riku Heikki Rautsola (image left) as the new CEO and president, Dr. Walter Kittl (image right) as the new chief operating officer, and effective in May 2018, Heiko Serwe as the new chief financial officer.
Rautsola has held several positions across the biopharmaceutical value chain and has, on several occasions, served as an interim executive for CordenPharma, according to the company.
Kittl has more than 35 years of experience in the pharmaceutical, CMO, and fine chemical industries. He has worked at Roche, where he was site manager of the Basel chemical manufacturing site, and at Siegfried AG, where he was president and general manager of Siegfried USA before being named head of global technical operations.
The new CFO, Serwe, will join the company in May from the industrial holding company Adcuram Group.
Dr. Macniell Esua, chief compliance officer and Dr. Michael Quirmbach, chief business officer, remain part of the CordenPharma International management team.